Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

被引：0
|
作者：
Jonsdottir, Gudbjorg
Bjorkholm, Magnus
Turesson, Ingemar
Hultcrantz, Malin
Porwit, Anna
Jethava, Yogesh
Landgren, Ola
Kristinsson, Sigurdur Y.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4396
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    [J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [2] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [3] DISSECTIONING RISK FACTORS FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML) AFTER AUTOTRANSPLANTS FOR PLASMA CELL MYELOMA AND LYMPHOMAS
    Hashmi, S.
    Dean, R. M.
    Shaw, B.
    Brazauskas, R.
    Millard, H.
    Battiwalla, M.
    Savani, B.
    Flowers, M. E.
    Cooke, K. R.
    Hamilton, B. K.
    Kalaycio, M.
    Radivoyevitch, T.
    Litzow, M. R.
    Gale, R. P.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S41 - S41
  • [4] Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis
    Jonsdottir, Gudbjorg
    Bjorkholm, Magnus
    Turesson, Ingemar
    Hultcrantz, Malin
    Porwit, Anna
    Jethava, Yogesh
    Landgren, Ola
    Kristinsson, Sigurdur Yngvi
    [J]. BLOOD, 2018, 132
  • [5] Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
    Mailankody, Sham
    Pfeiffer, Ruth M.
    Kristinsson, Sigurdur Y.
    Korde, Neha
    Bjorkholm, Magnus
    Goldin, Lynn R.
    Turesson, Ingemar
    Landgren, Ola
    [J]. BLOOD, 2011, 118 (15) : 4086 - 4092
  • [6] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    [J]. LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [7] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) WITH MYELOFIBROSIS
    IMBERT, M
    NGUYEN, D
    SULTAN, C
    [J]. LEUKEMIA RESEARCH, 1992, 16 (01) : 51 - 54
  • [9] Population pharmacokinetic modelling of decitabine in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Mistry, B.
    Gibiansky, L.
    Hussein, Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] EXTRAMEDULLARY LEUKEMIA (EML) IN MYELODYSPLASTIC SYNDROMES (MDS) - NOT A TRUE INDICATION OF IMPENDING ACUTE MYELOID-LEUKEMIA (AML)
    EDENFIELD, WJ
    BYRD, JC
    AYLESWORTH, C
    DOW, NS
    DAWSON, N
    [J]. BLOOD, 1994, 84 (10) : A631 - A631
12345